Improvement of Dry Mouth by Replacing Paroxetine with Fluvoxamine
Authors:
- 1 March 2005
- journal article
- case report
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 39 (3) , 567-571
Abstract
OBJECTIVE: To present a case of improvement of paroxetine-induced dry mouth by substitution of fluvoxamine and analyze this case based on receptor occupancy theory. CASE SUMMARY: A 66-year-old woman with major depressive disorder had been treated with brotizolam 0.5 mg/day, flunitrazepam 2 mg/day, sulpiride 100 mg/day, bromazepam 2 mg/day, trazodone 25 mg/day, and paroxetine hydrochloride 10 mg/day. Although her psychological symptoms improved gradually, she complained of dry mouth. Paroxetine was replaced with fluvoxamine maleate 50 mg/day, and the dryness disappeared within a month. DISCUSSION: We calculated the time courses of muscarinic acetylcholine (mACh) receptor occupancy after oral administration of paroxetine and fluvoxamine at the treatment doses by using pharmacokinetic parameters obtained from the literature. The mACh receptor occupancy was estimated to be decreased from 0.22% to 0.020% by replacing paroxetine with fluvoxamine. CONCLUSIONS: The improvement of dry mouth observed after the replacement of paroxetine with fluvoxamine in this patient may have been due to a decrease in the mACh receptor occupancy.Keywords
This publication has 11 references indexed in Scilit:
- Drug effects on salivary glands: dry mouthOral Diseases, 2003
- Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramineEuropean Journal of Pharmacology, 2002
- A randomised, double-blind comparison of milnacipran and imipramine in the treatment of depressionJournal of Affective Disorders, 2002
- CYP2D6 Inhibition by Selective Serotonin Reuptake Inhibitors: Analysis of Achievable Steady‐State Plasma Concentrations and the Effect of Ultrarapid Metabolism at CYP2D6Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitorsEuropean Journal of Clinical Pharmacology, 1998
- Quantitative Evaluation of Pharmacological Effects and Adverse Effects Based on Receptor Occupancy TheoryYAKUGAKU ZASSHI, 1997
- The interaction of antidepressant drugs with neurotransmitter receptor bidning sites and 5-HT uptake sites in human brain in vitroEuropean Neuropsychopharmacology, 1993
- The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.British Journal of Clinical Pharmacology, 1992
- Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitorPsychopharmacology, 1987
- A pharmacokinetic analysis program (multi) for microcomputer.Journal of Pharmacobio-Dynamics, 1981